Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HYL.BRthis companyHyloris Pharmaceuticals S.A.	€4.25	-29.74×	7.11×	26.14×	-20.46×	-236.5%	82.0%	-129.5%	-87.9%	-23.9%	-30.8%	-3.5%	0.06×	1.4×	-12.63×	3.89×	0.0%	2	8.47	1	D+
ALEMS.BREuropean Medical Solutions	€3.40	12.09×	1.82×	0.44×	7.5×	-715.8%	32.9%	5.4%	3.7%	15.3%	7.4%	11.3%	1.58×	2.94×	3.63×	1.43×	0.0%	5	1.72	3	B
CYAD.BRCelyad Oncology S.A.	€0.18	8.76×	2.99×	346.32×	-0.79×	-77.4%	9195.2%	-34200.0%	3952.4%	34.1%	366.4%	-94.9%	0×	0.24×	-112.22×	1.92×	0.0%	4	-221.13	4	A-
IBAB.BRIon Beam Applications S.A.	€16.02	30.05×	3×	0.62×	10.58×	-84.9%	32.2%	4.4%	2.0%	10.0%	7.2%	-9.2%	0.92×	1.27×	7.06×	0.99×	1.9%	5	1.51	3	B
ONONWD.BROnward Medical N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OXUR.BROxurion N.V.	€0.00	-0.06×	-0.02×	0.36×	-3.1×	-57867.8%	87.7%	-653.9%	-671.7%	28.9%	378.4%	-844.9%	-0.89×	-3.04×	-403.22×	0.11×	0.0%	3	-47.75	2	C
Peer median	—	10.43×	2.41×	0.53×	3.35×	-400.4%	60.3%	-324.7%	2.9%	22.1%	186.9%	-52.0%	0.46×	0.76×	-54.29×	1.21×	0.0%	5	-23.12	3	—